Navigation Links
Social Workers Honor William C. Bell with the International Rhoda G. Sarnat Award
Date:4/21/2008

NASW Foundation celebrates Bell's achievements at April 22 reception

WASHINGTON, April 22 /PRNewswire-USNewswire/ -- The National Association of Social Workers Foundation (NASWF) is proud to present William C. Bell, MSW, president and CEO of Casey Family Programs, with the 2007 International Rhoda G. Sarnat Award.

The International Rhoda G. Sarnat Award is given to an individual, group, or organization that has significantly advanced the public image of professional social work. This monetary prize is made possible from an endowment fund established by a generous contribution in 1996 from distinguished social worker Rhoda G. Sarnat, LCSW and Bernard Sarnat, MD.

"For more than 25 years, William Bell has been a tireless advocate for the welfare of children and an exemplary representative of social work values," says Elizabeth Clark, PhD, ACSW, MPH, president of NASWF. "His work has taken him from acting as a practitioner on the frontline, to providing management expertise to systems and he is now leading the largest national operating foundation that is focused on providing, improving and ultimately preventing the need for foster care."

Bell is one of America's leading experts in the foster care and child welfare community. He has served as president and CEO of Casey Family Programs since 2006. With his leadership, Casey Family Programs has initiated a long-term strategy, known as 2020. The 2020 strategy requires a comprehensive change in the foster care and child welfare systems and is aimed at safely reducing the number of children who come into foster care by fifty percent by the year 2020. The primary goal of this initiative is to ensure that every child has a safe, permanent family.

Bell will receive the 2007 International Rhoda G. Sarnat Award at a celebration honoring him on April 22 in Seattle.

Before joining Casey Family Programs, Bell served as commissioner of the Administration for Children's Services (ACS) i
'/>"/>

SOURCE National Association of Social Workers Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Rik Deitsch, CEO of Nutra Pharma Creates Personal Wall on WallSt.nets Financial Social Community, my.wallst.net
2. Older Americans are more socially engaged than many people may think
3. Joint Center Sees Social Determinants of Health as Key to Reducing Disparities at Annual Fund-raising Gala
4. 15 Million Americans Suffer From Social Anxiety Disorder
5. Animal Study Links Social Standing With Drug Use Risk
6. 2008 Social Security Report Offers Dire Warning
7. Social Problems in Youth Contribute to Anxiety, Depression
8. Pelosi Statement on Social Security and Medicare Trustees Reports
9. Blunt: Trustees Report is a Reminder of Medicare and Social Security Crisis
10. Media Alert: Statement on the Report of the Trustees of Social Security and Medicare
11. NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...27 With cold and flu season upon u...actices to control the spread of infections and av...ly to keep ourselves healthy, but to avoid transmi... RN, MS, CIC (certified in infection-control), nur...al health at Hospital for Special Surgery (HSS) in...
(Date:11/26/2009)... number of Americans living with diabetes will nea...o 44.1 million in 2034. Over the same period, spen...113 billion to $336 billion, even with no increase...t the University of Chicago report in the December... with diabetes covered by Medicare will rise from ...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...o more letters from the North Pole, Textsanta.net ...s from Santa , North Pole...al efficiencies at the North Pole Santa Claus has ... over the globe informed of his Christmas progress...earch department have identified a large and growi...
(Date:11/26/2009)...esearch Triangle Dental (RTDental), a leading dent... announced the expansion of its services to includ...oug Macmillan. , Durha...ed to announce that Dr. Doug Macmillan, an experie...ditional advanced training seminar. RTDental&rsqu...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...SAN CARLOS, Calif., Nov. 6 Nektar,Therapeutics (N...ased 32%, or,$100.0 million, of its outstanding co...ollar, for a total purchase price of $47.8 million...argely complete," said Nektar,President and CEO Ho...
...MK-677 brought muscle mass, but long-term effects ...URSDAY, Nov. 6 (HealthDay News) -- An experimenta...owth hormone in seniors to youthful levels, a new ...d to significant improvements in their strength or...
...Third quarter revenues increase 65 percent versus ... at 4:30 p.m. Eastern Time Today, IRVINE, Calif.,...worldwide leader in intravascular temperature,mana...months ended September 30, 2008., Revenue for the...
...Quarterly Revenue Exceeds $10 Million Company Del...tember, BEDFORD, Mass., Nov. 6 Insulet Corporati...nology with its OmniPod(R),Insulin Management Syst...lion compared to,$3.8 million in the third quarter...
..., Atlanta, Ga. November 06, 2008 Down syndrome,...mpairment, occurs in approximately 1-in-700 births...cent of fetuses with Down syndrome are lost before...urrent knowledge of Down syndrome, identify inform...
...STEWARTVILLE, Minn., Nov. 6 Rochester Medical,Cor...g results for its fourth,quarter and year ended Se...les of $9,512,000 for the current quarter,compared...733,000 or $.06 per diluted share for the fourth q...
Other Medicine News:Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 2Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 3Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 5Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 6Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 7Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 8Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 9Health News:Drug Boosts Natural Growth Hormone in Seniors 2Health News:Drug Boosts Natural Growth Hormone in Seniors 3Health News:Drug Boosts Natural Growth Hormone in Seniors 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 2Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 3Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 4Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 5Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 6Health News:Alsius Corporation Reports Record Third Quarter 2008 Financial Results and Business Progress 7Health News:Insulet Reports Third Quarter 2008 Results 2Health News:Insulet Reports Third Quarter 2008 Results 3Health News:Insulet Reports Third Quarter 2008 Results 4Health News:Insulet Reports Third Quarter 2008 Results 5Health News:Insulet Reports Third Quarter 2008 Results 6Health News:Insulet Reports Third Quarter 2008 Results 7Health News:Insulet Reports Third Quarter 2008 Results 8Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 2Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 3Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 4Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 5Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 6Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 7Health News:Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales 8
(Date:11/25/2009)...5 ChemoCentryx, Inc., announced ...pany,s PROTECT-1 (the Prospective Randomized Oral ...aficet-EN(TM) (CCX282-B) in patients with moderate...fficacy with a favorable safety and tolerability p...al efficacy in the reduction of disease severity a...
(Date:11/24/2009)...ewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: EL...or aortic disorders, announced today that it has f...ngs in, the patent infringement lawsuit brought ag... was filed in the United States District Court in ...ed that the stay remain in effect while the United...
(Date:11/24/2009)...re-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nas...at the 21st Annual Piper Jaffray Healthcare Confer... (6:00 a.m. PST). The conference is being held at... President and Chief Executive Officer of Anadys, ...l development programs, ANA598 and ANA773. ,, T...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2BEA Opens the Doors to the World at G20 Summit 58230 1BEA Opens the Doors to the World at G20 Summit 58230 2BEA Opens the Doors to the World at G20 Summit 58230 3Market Welby Hosting Free Urgent Care and Medical Practice Fast Growth Marketing Webinar Series 58228 1Market Welby Hosting Free Urgent Care and Medical Practice Fast Growth Marketing Webinar Series 58228 2Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 1Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 2Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 3Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 4Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 5
...il 7, 2008 Genta,Incorporated (Nasdaq: GNTA ) an... (oblimersen sodium) Injection, the Company,s lead...l meeting of the American Association,for Cancer R...ego, CA from,April 12-16, 2008. The subject matter...the Company,s ongoing randomized Phase 3 trial of,...
...8 VIA,Pharmaceuticals (Nasdaq: VIAP ), a biotech...unds for the treatment of cardiovascular disease,a...nitoring Board (DSMB),for its VIA-2291 Phase 2 cli... safety for its current Phase 2 studies. The DSMB ...VIA-2291 and recommended VIA,continue its ongoing ...
Other Medicine Technology:Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 2Specialized Genasense(R) Clinical Trials Featured at AACR Meeting 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4
...meter trial lens set has consistently been the mar...g only the highest level of quality throughout the...ns set continues to set the standard for excellenc...o the guidelines established by highly recognized ...
Non-Illuminated Trial Lens Set
Trial Lens Sets
L'Anthony's Desaturated 15 Hue Test
Medicine Products: